Evidence map›Paper›PMID 27328942›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.

Rohan Samarakoon, Alexandra Rehfuss, Nidah S Khakoo, Lucas L Falke, Amy D Dobberfuhl, Sevann Helo, Jessica M Overstreet, Roel Goldschmeding, Paul J Higgins

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  4. Article
  5. A comprehensive overview of PPM1A: From structure to disease.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  6. PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-β1-receptor signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  7. Article
  8. TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Review
  9. Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney diseaseFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  10. Review
  11. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rohan SamarakoonCenter for Cell Biology and Cancer Research, Albany Medical Center, Albany, New York, USA; samarar@mail.amc.edu.
Alexandra RehfussDivision of Urology, Albany Medical Center, Albany, New York, USA.
Nidah S KhakooCenter for Cell Biology and Cancer Research, Albany Medical Center, Albany, New York, USA.
Lucas L FalkeDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Amy D DobberfuhlDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA; and.
Sevann HeloDivision of Urology, Albany Medical Center, Albany, New York, USA.
Jessica M OverstreetDivision of Nephrology and Hypertension, Vanderbilt Medical School, Nashville, Tennessee, USA.
Roel GoldschmedingDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Paul J HigginsCenter for Cell Biology and Cancer Research, Albany Medical Center, Albany, New York, USA; higginp@mail.amc.edu.
Center for Cancer Research · USAlbany Medical Center Hospital · USUniversity Medical Center Utrecht · NLStanford University · USVanderbilt University Medical Center · US

Funding

MATRIX MEDIATORS OF WOUND HEALINGR01GM057242 · NIGMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI HIGGINS, PAUL J. · 1998 to 2010
$3.2M
NIGMS NIH HHS R01 GM057242
6 · The paper itself

Abstract

Protein phosphatase magnesium-dependent-1A (PPM1A) dephosphorylates SMAD2/3, which suppresses TGF-β signaling in keratinocytes and during Xenopus development; however, potential involvement of PPM1A in chronic kidney disease is unknown. PPM1A expression was dramatically decreased in the tubulointerstitium in obstructive and aristolochic acid nephropathy, which correlates with progression of fibrotic disease. Stable silencing of PPM1A in human kidney-2 human renal epithelial cells increased SMAD3 phosphorylation, stimulated expression of fibrotic genes, induced dedifferentiation, and orchestrated epithelial cell-cycle arrest via SMAD3-mediated connective tissue growth factor and plasminogen activator inhibitor-1 up-regulation. PPM1A stable suppression in normal rat kidney-49 renal fibroblasts, in contrast, promoted a SMAD3-dependent connective tissue growth factor and plasminogen activator inhibitor-1-induced proliferative response. Paracrine factors secreted by PPM1A-depleted epithelial cells augmented fibroblast proliferation (>50%) compared with controls. PPM1A suppression in renal cells further enhanced TGF-β1-induced SMAD3 phosphorylation and fibrotic gene expression, whereas PPM1A overexpression inhibited both responses. Moreover, phosphate tensin homolog on chromosome 10 depletion in human kidney-2 cells resulted in loss of expression and decreased nuclear levels of PPM1A, which enhanced SMAD3-mediated fibrotic gene induction and growth arrest that were reversed by ectopic PPM1A expression. Thus, phosphate tensin homolog on chromosome 10 is an upstream regulator of renal PPM1A deregulation. These findings establish PPM1A as a novel repressor of the SMAD3 pathway in renal fibrosis and as a new therapeutic target in patients with chronic kidney disease.-Samarakoon, R., Rehfuss, A., Khakoo, N. S., Falke, L. L., Dobberfuhl, A. D., Helo, S., Overstreet, J. M., Goldschmeding, R., Higgins, P. J. Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.

Indexed as

Cell LineConnective Tissue Growth FactorEpithelial CellsFibroblastsHumansKidneyMagnesiumPhosphorylationProtein Phosphatase 2CSignal TransductionSmad3 ProteinUp-RegulationConnective Tissue Growth FactorMagnesiumPPM1A protein, humanProtein Phosphatase 2CSmad3 ProteinSMAD3 protein, humanCTGFPAI-1PTENrenal fibrosisTGF-β

Identifiers

PMID27328942
PMCPMC5024688
OpenAlexW2462288202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.